3 Value Stocks Walking a Fine Line

via StockStory
ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

OC Cover Image

Value investing has produced some of the world’s most famous investing billionaires, including Warren Buffett, David Einhorn, and Seth Klarman, who built their fortunes by purchasing wonderful businesses at reasonable prices. But these hidden gems are few and far between - many stocks that appear cheap often stay that way because they face structural issues.

Identifying genuine bargains from value traps is something many investors struggle with, which is why we started StockStory - to help you find the best companies. Keeping that in mind, here are three value stocks with little support and some other investments you should consider instead.

Owens Corning (OC)

Forward P/E Ratio: 12.5x

Credited with the discovery of fiberglass, Owens Corning (NYSE:OC) supplies building and construction materials to the United States and international markets.

Why Do We Pass on OC?

  1. Annual revenue growth of 2.9% over the last two years was below our standards for the industrials sector
  2. Performance over the past two years shows its incremental sales were much less profitable, as its earnings per share fell by 20.2% annually
  3. Eroding returns on capital suggest its historical profit centers are aging

Owens Corning is trading at $130.86 per share, or 12.5x forward P/E. If you’re considering OC for your portfolio, see our FREE research report to learn more.

Align Technology (ALGN)

Forward P/E Ratio: 13.4x

Pioneering an alternative to traditional metal braces with nearly invisible plastic aligners, Align Technology (NASDAQ:ALGN) designs and manufactures Invisalign clear aligners, iTero intraoral scanners, and dental CAD/CAM software for orthodontic and restorative treatments.

Why Are We Cautious About ALGN?

  1. Muted 2.5% annual revenue growth over the last two years shows its demand lagged behind its healthcare peers
  2. Earnings growth over the last five years fell short of the peer group average as its EPS only increased by 1.4% annually
  3. Shrinking returns on capital suggest that increasing competition is eating into the company’s profitability

Align Technology’s stock price of $153.43 implies a valuation ratio of 13.4x forward P/E. Read our free research report to see why you should think twice about including ALGN in your portfolio.

Capital Southwest (CSWC)

Forward P/E Ratio: 10.8x

Originally founded in 1961 as a venture capital investor that helped launch Texas Instruments, Capital Southwest (NASDAQ:CSWC) is a business development company that provides debt and equity financing to middle-market companies primarily in the United States.

Why Do We Steer Clear of CSWC?

  1. Incremental sales over the last two years were much less profitable as its earnings per share fell by 6.2% annually while its revenue grew
  2. Below-average return on equity indicates management struggled to find compelling investment opportunities
  3. High net-debt-to-EBITDA ratio of 8× increases the risk of forced asset sales or dilutive financing if operational performance weakens

At $24.54 per share, Capital Southwest trades at 10.8x forward P/E. Check out our free in-depth research report to learn more about why CSWC doesn’t pass our bar.

Stocks We Like More

ONE MORE THING: Top 5 Growth Stocks. The biggest stock winners almost always had one thing in common before they ran. Revenue growing like crazy. Meta. CrowdStrike. Broadcom. Our AI flagged all three. They returned 315%, 314%, and 455%, respectively.

Find out which 5 stocks it’s flagging this month — FREE. Get Our Top 5 Growth Stocks for Free HERE.

Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,460% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Exlservice (+271% between June 2020 and June 2025). Find your next big winner with StockStory today.

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article